Metagenomi Therapeutics, Inc. (MGX): DEFA14A filed Apr 27, 2026

Form type

DEFA14A

Filing date

Apr 27, 2026

Accession number

0001193125-26-182339

Filer

Metagenomi Therapeutics, Inc. (CIK 1785279)